Cargando…

Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside

Botulinum neurotoxins (BoNTs) are one of the most toxic proteins known to humans. Their molecular structure is comprised of three essential domains—a cell binding domain (H(C)), translocation domain and catalytic domain (light chain) . The H(C) domain facilitates the highly specific binding of BoNTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregory, Kyle S., Liu, Sai Man, Acharya, K. Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050238/
https://www.ncbi.nlm.nih.gov/pubmed/31945264
http://dx.doi.org/10.1002/2211-5463.12790
_version_ 1783502593708785664
author Gregory, Kyle S.
Liu, Sai Man
Acharya, K. Ravi
author_facet Gregory, Kyle S.
Liu, Sai Man
Acharya, K. Ravi
author_sort Gregory, Kyle S.
collection PubMed
description Botulinum neurotoxins (BoNTs) are one of the most toxic proteins known to humans. Their molecular structure is comprised of three essential domains—a cell binding domain (H(C)), translocation domain and catalytic domain (light chain) . The H(C) domain facilitates the highly specific binding of BoNTs to the neuronal membrane via a dual‐receptor complex involving a protein receptor and a ganglioside. Variation in activity/toxicity across subtypes of serotype A has been attributed to changes in protein and ganglioside interactions, and their implications are important in the design of novel BoNT‐based therapeutics. Here, we present the structure of BoNT/A3 cell binding domain (H(C)/A3) in complex with the ganglioside GD1a at 1.75 Å resolution. The structure revealed that six residues interact with the three outermost monosaccharides of GD1a through several key hydrogen bonding interactions. A detailed comparison of structures of H(C)/A3 with H(C)/A1 revealed subtle conformational differences at the ganglioside binding site upon carbohydrate binding.
format Online
Article
Text
id pubmed-7050238
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70502382020-03-05 Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside Gregory, Kyle S. Liu, Sai Man Acharya, K. Ravi FEBS Open Bio Research Articles Botulinum neurotoxins (BoNTs) are one of the most toxic proteins known to humans. Their molecular structure is comprised of three essential domains—a cell binding domain (H(C)), translocation domain and catalytic domain (light chain) . The H(C) domain facilitates the highly specific binding of BoNTs to the neuronal membrane via a dual‐receptor complex involving a protein receptor and a ganglioside. Variation in activity/toxicity across subtypes of serotype A has been attributed to changes in protein and ganglioside interactions, and their implications are important in the design of novel BoNT‐based therapeutics. Here, we present the structure of BoNT/A3 cell binding domain (H(C)/A3) in complex with the ganglioside GD1a at 1.75 Å resolution. The structure revealed that six residues interact with the three outermost monosaccharides of GD1a through several key hydrogen bonding interactions. A detailed comparison of structures of H(C)/A3 with H(C)/A1 revealed subtle conformational differences at the ganglioside binding site upon carbohydrate binding. John Wiley and Sons Inc. 2020-01-28 /pmc/articles/PMC7050238/ /pubmed/31945264 http://dx.doi.org/10.1002/2211-5463.12790 Text en © 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Gregory, Kyle S.
Liu, Sai Man
Acharya, K. Ravi
Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title_full Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title_fullStr Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title_full_unstemmed Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title_short Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
title_sort crystal structure of botulinum neurotoxin subtype a3 cell binding domain in complex with gd1a co‐receptor ganglioside
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050238/
https://www.ncbi.nlm.nih.gov/pubmed/31945264
http://dx.doi.org/10.1002/2211-5463.12790
work_keys_str_mv AT gregorykyles crystalstructureofbotulinumneurotoxinsubtypea3cellbindingdomainincomplexwithgd1acoreceptorganglioside
AT liusaiman crystalstructureofbotulinumneurotoxinsubtypea3cellbindingdomainincomplexwithgd1acoreceptorganglioside
AT acharyakravi crystalstructureofbotulinumneurotoxinsubtypea3cellbindingdomainincomplexwithgd1acoreceptorganglioside